Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions.

The objective of this literature review was to evaluate the evidence pertaining to the impact of medication reviews and/or educational interventions on psychotropic drug use in long-term care facilities. A computerized search was conducted using MEDLINE, Cochrane Central Register of Control Trials, CINAHL, EMBASE, International Pharmaceutical Abstracts and PsycINFO, from January 1980 to April 2007. Controlled studies or randomized controlled studies were included for review. The authors identified 26 studies evaluating the impact of medication reviews and/or educational interventions on psychotropic drug use in long-term care facilities. Eleven studies met the inclusion criteria for this review and the data from six of these studies were included in a meta-analysis. The pooled odds ratio (OR) from five studies on hypnotic prescribing showed a decrease in use postintervention (OR = 0.57, 95% confidence intervals [CI] = 0.41-0.79). The pooled OR from five studies on prevalence of antipsychotic prescribing postintervention was not significant (OR = 0.81, 95% CI = 0.63-1.04). Medication reviews and/or educational interventions are effective at reducing psychotropic drug prescribing. However, research on the benefits of these interventions in reducing psychotropic drug use on total health care costs and resident health outcomes is lacking.

[1]  Anna Lee,et al.  Outreach pharmacy service in old age homes: a Hong Kong experience. , 2003, Journal of the Chinese Medical Association : JCMA.

[2]  B. Faragher,et al.  Effects of a pharmacist's medication review in nursing homes , 2000, British Journal of Psychiatry.

[3]  E. Roughead,et al.  Quality Use of Medicines in Aged-Care Facilities in Australia , 2003, Drugs & aging.

[4]  D. Challis,et al.  Depressed mood, cognitive impairment, and survival in older people admitted to care homes in England. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[5]  A D Oxman,et al.  Educational outreach visits: effects on professional practice and health care outcomes. , 2007, The Cochrane database of systematic reviews.

[6]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[7]  David R. Jones,et al.  Systematic Reviews and Meta-Analysis: A Structured Review of the Methodological Literature , 1999, Journal of health services research & policy.

[8]  P. Aslani,et al.  Australia and New Zealand Health Policy Open Access Community Pharmacy Services to Optimise the Use of Medications for Mental Illness: a Systematic Review , 2005 .

[9]  F. Matthews,et al.  Prevalence of dementia in institutional care , 2002, The Lancet.

[10]  N. Freemantle,et al.  Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial. , 2006, Age and ageing.

[11]  H. Brodaty,et al.  Use of Psychotropics in Sydney Nursing Homes: Associations With Depression, Psychosis, and Behavioral Disturbances , 2001, International Psychogeriatrics.

[12]  L. Melton,et al.  Psychotropic drug use and the risk of hip fracture. , 1987, The New England journal of medicine.

[13]  Giovambattista De Sarro,et al.  Adverse Effects of Atypical Antipsychotics in the Elderly , 2006, Drugs & aging.

[14]  T. Strandberg,et al.  Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[15]  S. Wegner,et al.  Pharmacist Response to Alerts Generated From Medicaid Pharmacy Claims in a Long-term Care Setting: Results From the North Carolina Polypharmacy Initiative , 2005, Journal of managed care pharmacy : JMCP.

[16]  W A Ray,et al.  Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. , 1994, JAMA.

[17]  R. Cumming,et al.  Benzodiazepines and Risk of Hip Fractures in Older People , 2003, CNS drugs.

[18]  W. Ray,et al.  Predictors of Antipsychotic Withdrawal or Dose Reduction in a Randomized Controlled Trial of Provider Education , 1997, Journal of the American Geriatrics Society.

[19]  W. Ray,et al.  Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. , 1995, American journal of epidemiology.

[20]  J. Luxenberg,et al.  Antipsychotics for delirium. , 2007, The Cochrane database of systematic reviews.

[21]  Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes , 2001, Pharmacy World and Science.

[22]  I. C. Wiseman,et al.  Pharmacist intervention in an elderly care facility , 1996 .

[23]  K. Khunti,et al.  Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents. , 2000, Age and ageing.

[24]  S. Rubin,et al.  A drug burden index to define the functional burden of medications in older people. , 2007, Archives of internal medicine.

[25]  B. Svarstad,et al.  The Impact of Regular Multidisciplinary Team Interventions on Psychotropic Prescribing in Swedish Nursing Homes , 1998, Journal of the American Geriatrics Society.

[26]  K. Taxis,et al.  A study of medication reviews to identify drug‐related problems of polypharmacy patients in the Dutch nursing home setting , 2007, Journal of clinical pharmacy and therapeutics.

[27]  S. Ruths,et al.  Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study , 2003, Quality & safety in health care.

[28]  Philip S. Insel,et al.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[29]  D. Kay,et al.  Psychiatric Morbidity in Hobart's Dependent Aged , 1987, The Australian and New Zealand journal of psychiatry.

[30]  J. Touchon,et al.  Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study , 2006, BMJ : British Medical Journal.

[31]  S. Borson,et al.  Psychiatric Assessments of Nursing Home Residents Under OBRA‐87: Should PASARR Be Reformed? , 1997, Journal of the American Geriatrics Society.

[32]  S. Zimmerman,et al.  Some predictors of psychiatric consultation in nursing home residents. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[33]  D. Bates,et al.  Risk factors for adverse drug events among nursing home residents. , 2001, Archives of internal medicine.

[34]  P. Routledge,et al.  Adverse drug reactions in elderly patients. , 2003, British journal of clinical pharmacology.

[35]  G. Schneider,et al.  Old and ill and still feeling well? Determinants of subjective well-being in >or=60 year olds: the role of the sense of coherence. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[36]  L. Teri,et al.  Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition. , 1991, Journal of gerontology.

[37]  S R Salem-Schatz,et al.  A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. , 1992, The New England journal of medicine.

[38]  H. Davies,et al.  Does Organisational Culture Influence Prescribing in Care Homes for Older People? , 2007, Drugs & aging.

[39]  B. Svarstad,et al.  Chronic Benzodiazepine Use in Nursing Homes: Effects of Federal Guidelines, Resident Mix, and Nurse Staffing , 2001, Journal of the American Geriatrics Society.

[40]  Y. Yip,et al.  The association between medications and falls in Australian nursing‐home residents , 1994, The Medical journal of Australia.

[41]  D. West,et al.  Drug regimen review in skilled nursing facilities by consulting clinical pharmacists. , 1980, American journal of hospital pharmacy.

[42]  K. Lapane,et al.  Adherence to the components of the Fleetwood model: self-reported process measures in the Fleetwood Phase III study. , 2006, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

[43]  S. Wegner,et al.  A pharmacy management intervention for optimizing drug therapy for nursing home patients. , 2004, The American journal of geriatric pharmacotherapy.

[44]  F Sturmans,et al.  Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. , 1995, Archives of internal medicine.

[45]  M J Lichtenstein,et al.  Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. , 1993, Archives of internal medicine.

[46]  Liam Smeeth,et al.  Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. , 2003, American journal of epidemiology.

[47]  J. Garrard,et al.  The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes. , 1995, American journal of public health.

[48]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[49]  J. Fastbom,et al.  Quality of Drug Use in Swedish Nursing Homes , 1999 .

[50]  C. Dufouil,et al.  Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging Study , 2002, Journal of clinical psychopharmacology.

[51]  K. Pitkälä,et al.  Use of Psychotropic Drugs in Elderly Nursing Home Residents with and without Dementia in Helsinki, Finland , 2005, Drugs & aging.

[52]  Judith K Jones,et al.  Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[53]  M. King,et al.  Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. , 2001, British journal of clinical pharmacology.

[54]  K. Lapane,et al.  Administrative Initiatives for Reducing Inappropriate Prescribing of Psychotropic Drugs in Nursing Homes , 2005, Drugs & aging.

[55]  J. O'Brien,et al.  Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments , 2001, International journal of geriatric psychiatry.

[56]  P. V. Laucka,et al.  Decreasing medication use in a nursing-home patient-care unit. , 1992, American journal of hospital pharmacy.

[57]  L. Ried,et al.  Benzodiazepine Exposure and Functional Status in Older People , 1998, Journal of the American Geriatrics Society.

[58]  J. Snowdon,et al.  Psychotropic drug use in Sydney nursing homes , 1995, The Medical journal of Australia.

[59]  Sarah N Hilmer,et al.  Clinical pharmacology in the geriatric patient , 2007, Fundamental & clinical pharmacology.

[60]  Robert Howard,et al.  Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial , 2006, BMJ : British Medical Journal.

[61]  Tom Fahey,et al.  Interventions used to improve control of blood pressure in patients with hypertension. , 2010, The Cochrane database of systematic reviews.

[62]  B. Burns,et al.  Prescribing of Psychotropics in Elderly Nursing Home Patients , 1989, Journal of the American Geriatrics Society.

[63]  R. Cumming,et al.  Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[64]  W. Schaffner,et al.  Reducing antipsychotic drug prescribing for nursing home patients: a controlled trial of the effect of an educational visit. , 1987, American journal of public health.

[65]  Alan Shiell,et al.  Complex interventions: how “out of control” can a randomised controlled trial be? , 2004, BMJ : British Medical Journal.

[66]  Mitchell J Barnett,et al.  Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. , 2006, The American journal of geriatric pharmacotherapy.

[67]  M. Ryan,et al.  Long-term cognitive impact of anticholinergic medications in older adults. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[68]  M. Crotty,et al.  An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475] , 2004, BMC health services research.